TXNIP potentiates Redd1-induced mTOR suppression through stabilization of Redd1

@article{Jin2011TXNIPPR,
  title={TXNIP potentiates Redd1-induced mTOR suppression through stabilization of Redd1},
  author={Hongjuan Jin and S Seo and Y-S Kim and Sang Hyeok Woo and K-H Lee and Jae Youn Yi and S-J. Lee and Tae-boo Choe and J.-H. Lee and Sungkwan An and S-I Hong and I Park},
  journal={Oncogene},
  year={2011},
  volume={30},
  pages={3792-3801}
}
The mammalian target of rapamycin (mTOR) is a highly conserved serine–threonine kinase activated in response to growth factors and nutrients. Because of frequent dysregulation of the mTOR signaling pathway in diverse human cancers, this kinase is a key therapeutic target. Redd1 is a negative regulator of mTOR, mediating dissociation of 14-3-3 from tuberous sclerosis complex (TSC)2, which allows formation of a TSC–TSC2 complex. In the present study, we identify TXNIP that inhibits mTOR activity… 
Thioredoxin-1 maintains mechanistic target of rapamycin (mTOR) function during oxidative stress in cardiomyocytes
TLDR
The results suggest that Trx1 protects cardiomyocytes against stress by reducing mTOR at Cys-1483, thereby preserving the activity of mTOR and inhibiting cell death.
The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile
TLDR
This work shows that the ATP-competitive inhibitor PP242, but not rapamycin, significantly down-regulates cholesterol biosynthesis genes in a 4E-BP1–dependent manner in NIH 3T3 cells, whereas S6 kinase 1 is the dominant regulator in hepatocellular carcinoma cells.
MondoA-Mlx Transcriptional Activity Is Limited by mTOR-MondoA Interaction
TLDR
A regulatory relationship between mTOR and the MondoA-TXNIP axis is revealed that contributes to glucose homeostasis and is revealed to be physically and functionally related.
Trx 1 as a co-factor of mTOR 1 Thioredoxin-1 maintains mTOR function during oxidative stress in cardiomyocytes
TLDR
The results suggest that Trx1 protects cardiomyocytes against stress by reducing mTOR at Cys1483, thereby preserving the activity of mTOR and inhibiting cell death.
A REDD1/TXNIP pro-oxidant complex regulates ATG4B activity to control stress-induced autophagy and sustain exercise capacity
TLDR
In Redd1−/− mice, deregulated ATG4B activity and disabled autophagic flux cause accumulation of defective mitochondria, leading to impaired oxidative phosphorylation, muscle ATP depletion and poor exercise capacity, revealing a new mechanism of autophagy control whose deregulation disrupts mitochondrial integrity and energy homeostasis in vivo.
Silencing of Twist1 sensitizes NSCLC cells to cisplatin via AMPK-activated mTOR inhibition
TLDR
In conclusion, silencing of Twist1 sensitizes lung cancer cells to cisplatin via stimulating AMPK-induced mTOR inhibition, leading to a reduction in Mcl-1 protein.
Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms.
TLDR
Sequence analysis revealed that TXNIP is a member of the classical visual/β-arrestin superfamily, and is one of the six members of the arrestin domain-containing (ARRDC, or α-Arrestin) family, supporting the importance of redox independent functions ofTXNIP.
Inhibition of SIRT1/2 upregulates HSPA5 acetylation and induces pro-survival autophagy via ATF4-DDIT4-mTORC1 axis in human lung cancer cells
TLDR
The data show that combinatorial treatment with SIRT1/2 inhibitors and pharmacological autophagy inhibitors is an effective therapeutic strategy for cancer therapy, and shows that inhibition of SIRT 1/2 induces pro-survivalAutophagy via acetylation of HSPA5 and subsequent activation of ATF4 and DDIT4 to inhibit the mTOR signaling pathway in NSCLC cells.
Fatty Acid Synthase inhibition engages a novel caspase-2 regulatory mechanism to induce ovarian cancer cell death
TLDR
It is shown that the initiator caspase-2 is required for robust death of ovarian cancer cells induced by FASN inhibitors, placing mTOR as a novel upstream regulator of caspasing-2 and supporting the possibility of manipulating mTOR to enhance caspases-2 activation in ovarian cancer.
...
...

References

SHOWING 1-10 OF 49 REFERENCES
Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling.
TLDR
It is demonstrated that hypoxia and REDD1 suppress mammalian TORC1 (mTORC1) activity by releasing TSC2 from its growth factor-induced association with inhibitory 14-3-3 proteins, which defines a molecular mechanism of signal integration by TSC1/2 that provides insight into the ability of REDD 1 to function in a hypoxIA-dependent tumor suppressor pathway.
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.
TLDR
It is shown that mTOR inhibition by hypoxia requires the TSC1/TSC2 tumor suppressor complex and the Hypoxia-inducible gene REDD1/RTP801 to be inhibited, and that down-regulation of mTOR activity by hyp oxia requires de novo mRNA synthesis and correlates with increased expression of the hypoxIA-Inducible REDD 1 gene.
Dexamethasone Represses Signaling through the Mammalian Target of Rapamycin in Muscle Cells by Enhancing Expression of REDD1*
TLDR
The data support the conclusion that REDD1 functions upstream of Tuberin and Rheb to down-regulate mTOR signaling in response to dexamethasone.
REDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A–DDB1 ubiquitin ligase
TLDR
It is shown that REDD1 is subject to ubiquitin‐mediated degradation mediated by the CUL4A–DDB1–ROC1–β‐TRCP E3 ligase complex and through the activity of glycogen synthase kinase 3β, which is crucially required for the restoration of mTOR signalling as cells recover from hypoxic stress.
Functional consequences of mTOR inhibition.
TLDR
This review describes some recent advances in the understanding of m TOR signaling, with an emphasis on the functional consequences of mTOR inhibition and therapeutic intervention strategies.
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
TLDR
It is shown that metformin, one of the most widely prescribed type 2 diabetes therapeutics, requires LKB1 in the liver to lower blood glucose levels, and TORC2 is a critical target of L KB1/AMPK signals in the regulation of gluconeogenesis.
Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis
TLDR
Together, these findings uncover a specific genetic mechanism for HIF induction through loss of REDD1, which is defined as a key metabolic regulator that suppresses tumorigenesis through distinct effects on mTORC1 activity and mitochondrial function.
Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40
TLDR
Findings identify PRAS40 as an important regulator of insulin sensitivity of the Akt–mTOR pathway and a potential target for the treatment of cancers, insulin resistance and hamartoma syndromes.
Targeting mTOR globally in cancer: Thinking beyond rapamycin
TLDR
Recent studies that highlight the emergence of rapamycin-resistant mTOR function in protein synthesis, cell growth, survival and metabolism are discussed, and it is shown that these rap amycin- resistant mTOR functions are profoundly inhibited by TKIs.
...
...